Nuveen’s UiPath PATH Stock Holding History

Nuveen’s Portfolio PATH Stock Details PATH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-68,000	Closed	-$5K	–	3445
2021 Q2	$5K	Buy	+68,000	New	+$4.99M	﹤0.01%	3317

Other funds holding PATH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

TAM

TFG Asset Management Grand Cayman, Cayman Islands $515M AUM 24.47% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return

Nuveen's PATH Position: Q1 2026 in Review

Nuveen reduced its UiPath (PATH) stake by 50% in Q1 2026, selling an estimated $12.8M and leaving 1,007,403 shares worth $11.2M. The position accounts for ﹤0.01% of the portfolio, ranked #1487.

Nuveen first reported a position in PATH in Q2 2021 and has held it in 19 quarters since. The position peaked at $167M in Q2 2021. 533 funds tracked by Wall St. Rank hold PATH as of Q1 2026.

Nuveen held 1,007,403 shares of UiPath worth $11.2M as of Q1 2026.
Nuveen sold 1,001,805 UiPath shares in Q1 2026, an estimated $12.8M.
UiPath made up ﹤0.01% of Nuveen's portfolio in Q1 2026, its #1487 holding.
Nuveen first reported a position in UiPath in Q2 2021 and has held it in 19 quarters since.
Nuveen's UiPath position peaked at $167M in Q2 2021.
533 funds tracked by Wall St. Rank held UiPath as of Q1 2026.

Based on Nuveen's 13F filing for Q1 2026, filed 30 Apr 2026.